First, we demonstrate that genetic loss of individual MCP genes in stromal cells results in improved survival of PDGFB-driven tumor-bearing mice with no change in myeloid content, while loss of individual MCPs from both stromal and tumor cells abolishes survival advantage. Here, PDGFB is linked to neoplasm.